GTA: Glyceryltriacetate

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
307	カナバン病	1

307. カナバン病

臨床試験数 : 6 / 薬物数 : 11 - (DrugBank : 5) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 2

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00278707 (ClinicalTrials.gov)	January 2006	15/1/2006	GTA-Glyceryltriacetate for Canavan Disease	Phase 1 Treatment With GTA in Two Infant With Canavan Disease	Infantile Canavan Disease;Deficiency Disease, Aspartoacylase	Drug: GTA: Glyceryltriacetate	Sheba Medical Center	NULL	Active, not recruiting	N/A	15 Months	Both	5	Phase 1	Israel